About Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals is a Healthcare company. Pharmaceutical manufacturing and marketing of therapeutic solutions in India. The company has 40 employees. Its Indian entity Indospectrum Pharmaceuticals Private Limited reported revenue of ₹7.88 Cr. Indo Spectrum Pharmaceuticals offers products and services including Docosa and Spectrofer Tablet. Its focus areas include Pharmaceuticals, Drug Manufacturing, Therapeutic Solutions and Medical Specialities.
Company details
Indo Spectrum Pharmaceuticals was founded as a firm in Karnataka on October 21, 2007, and was incorporated in 2009 to deliver quality innovative therapeutic solutions. The companys operations are guided by the principle of Bring Colours to Life, which is used to inform all actions and maintain trust among the medical fraternity. Various specialities such as Gynaecology, Cardiology, and Diabetology are served, with a focus on exceeding customer expectations and prioritizing patient interests. Ethical practices and sustained growth are emphasized, along with introductions of first-time products in India. The company is positioned within the dynamic pharmaceutical industry through its marketing innovations and committed sales efforts.
- Employees 40
- SectorsHealthcare
- Email••••••••
- Website indospectrum.in
- Legal Name Indo Spectrum Pharmaceuticals Private Limited
- Date of Incorporation 23 Sep, 2009
- Jurisdiction Mysore, Karnataka, India
- Indian entity revenue₹7.88 Cr
FY 2025 · +13% YoY
- Indian entity net profit₹47.3 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹67.9 Lakh
FY 2025 · 9% margin
- Employee Count40
Associated legal entities of Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals operates through Indospectrum Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Indospectrum Pharmaceuticals Private Limited CIN U51109KA2009PTC051010 | Active | 23 Sep 2009 | Mysore, Karnataka | ₹7.9 Cr | 40 | 2 | View details |
Products & Services of Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals offers a comprehensive portfolio of products and services, including Docosa and Spectrofer Tablet.
Docosa is provided as a therapeutic solution in the company's lineup of formulations.
Spectrofer Tablet is offered as part of the company's range of innovative pharmaceutical products.
Board of directors of Indospectrum Pharmaceuticals Private Limited (Indo Spectrum Pharmaceuticals)
Indospectrum Pharmaceuticals Private Limited is the primary company behind Indo Spectrum Pharmaceuticals. The board of Indospectrum Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Venkatachalapathi Nagaraj, appointed in 2009. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkatachalapathi Nagaraj DIN 02683487 | Director | 23 Sep 2009 | 17 yrs 1 mo | Indospectrum Pharmaceuticals Private Limited |
| Ravishkumar DIN 02683454 | Director | 05 Mar 2010 | 16 yrs 8 mo | Indospectrum Pharmaceuticals Private Limited |
Financials of Indo Spectrum Pharmaceuticals
Figures of Indospectrum Pharmaceuticals Private Limited, the primary company behind Indo Spectrum Pharmaceuticals, for FY 2025. Revenue was ₹7.88 Cr (+13% year on year). Net profit was ₹47.3 Lakh (6% margin). EBITDA was ₹67.9 Lakh (9% margin). Revenue has grown at a compounded annual rate of +10% over three years.
- ₹7.88 CrRevenue · FY 2025 · +13% YoY
- ₹47.3 LakhNet profit · 6% margin
- ₹67.9 LakhEBITDA · 9% margin
- ₹8.1 LakhPaid-up capital
- 40Employees (provident fund records)
- +10%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Indospectrum Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Indo Spectrum Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Indo Spectrum Pharmaceuticals
Indo Spectrum Pharmaceuticals has 40 employees.
The primary company behind Indo Spectrum Pharmaceuticals, Indospectrum Pharmaceuticals Private Limited, reported revenue of ₹7.88 Cr for FY 2025, up 13% year on year.
Indo Spectrum Pharmaceuticals was founded as a firm in Karnataka on October 21, 2007, and was incorporated in 2009 to deliver quality innovative therapeutic solutions. The companys operations are guided by the principle of Bring Colours to Life, which is used to inform all actions and maintain trust among the medical fraternity. Various specialities such as Gynaecology, Cardiology, and Diabetology are served, with a focus on exceeding customer expectations and prioritizing patient interests. Ethical practices and sustained growth are emphasized, along with introductions of first-time products in India. The company is positioned within the dynamic pharmaceutical industry through its marketing innovations and committed sales efforts.
Indo Spectrum Pharmaceuticals offers Docosa and Spectrofer Tablet.
Indo Spectrum Pharmaceuticals operates through Indospectrum Pharmaceuticals Private Limited.
The legal entities of Indo Spectrum Pharmaceuticals currently have 2 directors, including Venkatachalapathi Nagaraj, Ravishkumar.